Table 3.

Relationship Between Neutrophil-to-Lymphocyte Ratio and Severity of Liver Fibrosis

Outcome	Crude Model		Model I		Model II
	β (95% CI)	P	β (95% CI)	P	β (95% CI)	P
NLR	0.52 (0.27-0.77)	<.001	0.49 (0.24-0.75)	<.001	0.57 (0.22-0.92)	.001
NLR (quartile)
Q1	Reference		Reference		Reference
Q2	0.54 (−0.12-1.19)	.109	0.41 (−0.26-1.08)	.228	0.25 (−0.65-1.16)	.586
Q3	1.10 (0.44-1.75)	.001	0.96 (0.28-1.64)	.006	0.93 (0.03-1.84)	.044
P for trend	.001		.005		.043

Model I adjusted for age, sex, race. Model II adjusted for age, sex, race, education level, body mass index, physical activity, smoking status, alanine transaminase, aspartate aminotransferase, alkaline phosphatase, gamma glutamyl transferase, total bilirubin, triglyceride–glucose index, hypertension, and diabetes.

NLR, neutrophil-to-lymphocyte ratio.